Diabetes, myocardial infarction and stroke are distinct and duration-dependent predictors of subsequent cardiovascular events and all-cause mortality in older men

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 3, 2015, Pages 1038-1047

  Yeap, Bu B ^a,b   McCaul, Kieran A ^c   Flicker, Leon ^a,c   Hankey, Graeme J ^a,d   Almeida, Osvaldo P ^c,e   Golledge, Jonathan ^f   Norman, Paul E ^e  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FIONA STANLEY HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

AGED; ALCOHOL CONSUMPTION; ARTICLE; AUSTRALIA; BODY MASS; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; EDUCATIONAL STATUS; GROUPS BY AGE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBESITY; ONSET AGE; PHYSICAL INACTIVITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; VERY ELDERLY; AGING; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGY; MORTALITY; MYOCARDIAL INFARCTION; PROGNOSIS; STROKE; TIME;

AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DIABETES MELLITUS, TYPE 2; HUMANS; LONGITUDINAL STUDIES; MALE; MYOCARDIAL INFARCTION; PROGNOSIS; STROKE; TIME FACTORS; WESTERN AUSTRALIA;

EID: 84925003951     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-3339     Document Type: Article

References (41)

1. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants Lancet. 2011;378:31-40.
2. Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care. 2012;35:2650-2664.
3. World Health Organisation. Diabetes. (Fact sheet No. 312) WHO, 2011.
4. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care. 1998;21:1138-1145.
5. Saydah SH, Eberhardt MS, Loria CM, Brancati FL. Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol. 2002;156:714-719.
6. Campbell PT, Newton CC, Patel AV, Jacobs EJ, Gapstur SM. Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care. 2012;35:1835-1144.
7. The Emerging Risk Factors Collaboration. Diabetes Mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364:829-841.
8. Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990-2010. New Engl J Med. 2014;370:1514-1523.
9. Shah AS, Dolan LM, Kimball TR, et al. Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009;94:3740-3745.
10. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. NEngl J Med. 2008;359:1577-1589.
11. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545-2559.
12. ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560-2572.
13. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129-139.
14. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35:1364-1379.
15. Norman PE, Jamrozik K, Lawrence-Brown MM, et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ. 2004;329:1259.
16. Norman PE, Flicker L, Almeida OP, Hankey GJ, Hyde Z, Jamrozik K. Cohort Profile: The Health In Men Study (HIMS). Int J Epidemiol. 2009;38:48-52.
17. Holman CD, Bass AJ, Rosman DL, et al. A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage system. Aust Health Rev. 2008;32:766-777.
18. Barr EL, Tonkin AM, Welborn TA, Shaw JE. Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: the AusDiab study. Int Med J. 2009;39:49-53.
19. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
20. Morgan CL, Currie CJ, Peters JR. Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care. 2000;23:1103-1107.
21. Barr EL, Zimmet PZ, Welborn TA, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance. Circulation. 2007;116:151-157.
22. Idris I. Diabetes and cardiovascular risk equivalency: do age at diagnosis and disease duration affect risk stratification?: comment on "impact of diabetes on cardiovascular disease risk and all-cause mortality in older men". Arch Intern Med. 2011;171:410-411.
23. Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370:1829-1839.
24. Fox CS, Sullivan L, D'Agostino RB Sr, Wilson PW. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care. 2004;27:704-708.
25. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med. 2011;171:404-410.
26. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
27. Schramm TK, Gislason GH, Køber L, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk. a population study of 3.3 million people. Circulation. 2008;117:1945-1954.
28. Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol. 2002;40:954-960.
29. Lee CD, Folsom AR, Pankow JS, Brancati FL. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation. 2004;109:855-860.
30. Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J. Impact of diabetes and previous myocardial infarction on long-term survival. 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch Intern Med. 2004;164:1438-1443.
31. Pajunen P, Koukkunen H, Ketonen M, et al. Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study. Diabetologia. 2005;48:2519-2524.
32. Zoungas S, Woodward M, Li Q, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57:2465-2474.
33. Majesky MW. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol. 2007;27:1248-1258.
34. Kim JS, Nah HW, Park SM, et al. Risk factors and stroke mechanisms in atherosclerotic stroke. intracranial compared with extracranial and anterior compared with posterior circulation disease. Stroke. 2012;43:3313-3318.
35. Williams KJ. Editorial: The mystery-and importance-of diabetic atherosclerotic vascular disease. J Clin Endocrinol Metab. 2002;87:33-34.
36. Ankam J, Feldman DI, Blaha MJ, Martin SS. Improving lipid control following myocardial infarction. Curr Opin Cardiol. 2014;29:454-466.
37. Dale AC, Vatten LJ, Nilsen TI, Midthjell K, Wiseth R. Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study. BMJ. 2008;337:a236.
38. Nauta ST, Deckers JW, Akkerhuis KM, van Domburg RT. Short-and long-term mortality after myocardial infarction in patients with and without diabetes. changes from 1985 to 2008. Diabetes Care. 2012;35:2043-2047.
39. Zhao W, Katzmarzyk PT, Horswell R, et al. Blood pressure and stroke risk among diabetic patients. J Clin Endocrinol Metab. 2013;98:3653-3662.
40. Halban PA, Polonsky KS, Bowden DW, et al. β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. J Clin Endocrinol Metab. 2014;99:1983-1992.
41. Bruce DG, Davis WA, Davis TM. Glycemic control in older subjects with Type 2 diabetes mellitus in the Fremantle Diabetes Study. J Am Geriatr Soc. 2000;48:1449-1453.